心源性脑卒中诊断中血生化标志物检查的临床应用(3)
 |
| 第1页 |
参见附件(2049KB，3页)。
[6] Panteghini M.Role and importance of biochemical markers in clinical cardiology.Eur Heart J,2004,25:1187 1196.
[7] Brosnan MJ,Clark JS,Jeffs B,et al.Genes encoding atrial and brain natriuretic peptides as candidates for sensitivity to brain ischemia in stroke prone hypertensive rats.Hypertension,1999,33:290 297.
[8] Ma¨kikallio AM,Ma¨kikallio TH,Korpelainen JT,et al.Natriuretic peptides and mortality after stroke.Stroke,2005,36:1016 1020.
[9] Joan Montaner,Mila Perea Gainza,Pilar Delgado,et al.Etiologic Diagnosis of Ischemic Stroke Subtypes With Plasma Biomarkers.Stroke,2008,39:2280 2287.
[10] Lynch JR,Blessing R,White WD,et al.Novel diagnostic test for acute stroke.Stroke,2004,35:57 63.
[11] Levin ER,Gardner DG,Samson WK.Natriuretic peptides.N Engl J Med,1998,339:321 328.
[12] Nakagawa K,Yamaguchi T,Seida M,et al.Plasma concentrations of brain natriuretic peptides in patients with acute ischemic stroke.Cerebrovasc Dis,2005,19:157 164.
[13] Inoue S,Murakami Y,Sano K,et al.Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation.J Card Failure,2000,6:92 96.
[14] Shimizu H,Murakami Y,Inoue S,et al.High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation.Stroke,2002,33:1005 1010.
[15] Tohgi H,Kawashima M,Tamura K,et al.Coagulation fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism.Stroke,1990,21:1663 1667.
您现在查看是摘要介绍页，详见PDF附件(2049KB，3页)。